Dr. Lubna Pal, MD, is a Director of the Reproductive Aging and Bone Health Program at Yale Reproductive Endocrinology, specializing in the areas of infertility, reproductive aging and menopause, low bone mineral density (osteopenia and osteoporosis), and reproductive endocrinology. She discusses Vitamin D insufficicency in women with polycystic ovarian syndrome and a 3 month intervention trial she is conducting.
Vitamin D insufficiency occurs in as many as 80-90% of women with PCOS. In these patients, Vitamin D may improve insulin sensitivity parameters, reduce proinflammatory markers and benefit circulating androgen profile.
References and Resources
Kotsa K, Yavropoulou MP, Anastasiou O, Yovos JG Role of vitamin D treatment in glucose metabolism in polycystic ovary syndrome. Fertil Steril. 2008 Oct 16. [Epub ahead of print]
Sponsored by The Doctor’s Channel